Newsroom

LAS VEGAS--(BUSINESS WIRE)--The recently concluded SupplySide Global 2025 was hailed as “the best ever” by a senior dietary supplement expert, who highlighted bioavailability as the defining frontier for health supplements in 2026. As “high content” gives way to “high absorption,” CELFULL - a clinically driven anti-aging health brand - unveiled Celfavor NADH, a controlled-release microsphere technology that elevates nutrient absorption to an unprecedented level, which is of epoch-making signifi...

LAS VEGAS--(BUSINESS WIRE)--L’evento SupplySide Global 2025, appena concluso, è stato definito “il migliore di sempre” da un noto esperto di integratori alimentari, che ha indicato la biodisponibilità come il principale ambito di innovazione per gli integratori per la salute nel 2026. In questo scenario, in cui il concetto di “alta concentrazione” lascia il posto a quello di “alto assorbimento”, CELFULL – un brand anti-age basato sulla ricerca clinica – ha presentato Celfavor™ NADH, una tecnolo...

LAS VEGAS--(BUSINESS WIRE)--Le salon SupplySide Global 2025, qui vient de fermer ses portes, a été salué comme « le meilleur jamais organisé » par un expert chevronné en compléments alimentaires, qui a souligné que la biodisponibilité serait le critère déterminant pour les compléments alimentaires en 2026. Alors que le « haut contenu » cède la place à la « haute absorption », CELFULL, une marque de santé anti-âge axée sur la clinique, a dévoilé Celfavor NADH, une technologie de microsphères à l...

SINGAPORE--(BUSINESS WIRE)--NielsenIQ (NIQ) (NYSE: NIQ), a leader in consumer intelligence, announced the launch of its enhanced FMCG E-commerce Measurement Solution in Indonesia, Singapore, and Thailand. Developed specifically for the fast-moving consumer goods (FMCG) industry, the solution empowers brands and retailers with a single, harmonized view of e-commerce sales performance, complementing NIQ’s Retail Measurement Service (RMS) for offline markets. According to NIQ, by 2030, 30% of all...

HANOI, Vietnam--(BUSINESS WIRE)--FPT, Global IT company, announced today that it has achieved the AWS Generative AI Competency. This specialization recognizes FPT as an AWS Partner that helps customers and the AWS Partner Network drive the advancement of services, tools, and infrastructure pivotal for implementing generative AI technologies. Achieving the AWS Generative AI Competency sets FPT apart as an AWS Partner that has demonstrated technical proficiency and proven customer success in supp...

DUBAI, United Arab Emirates--(BUSINESS WIRE)--CDB Aviation, a wholly owned Irish subsidiary of China Development Bank Financial Leasing Co., Ltd. (“CDB Leasing”), announced today the execution of lease agreements for two Boeing 737 MAX 8 aircraft with Africa's largest airline, Ethiopian Airlines (“Ethiopian”). “On behalf of CDB Aviation, I am very proud to welcome Ethiopian Airlines to our global customer family, with the lease agreements executed for these two Boeing 737 MAX 8 aircraft to be d...

SINGAPORE--(BUSINESS WIRE)--KKR Provides $750 Million Bespoke Financing Solution to Chandra Asri Group...

BANGKOK--(BUSINESS WIRE)--Grand Nikko Bangkok Sathorn, the first Grand Nikko-branded hotel in Thailand, begins accepting reservations for 2026 stays on November 17, 2025....

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into The Beauty Health Company (“Beauty Health” or the “Company”) (NasdaqCM: SKIN). In November 2023, the Company announced its financial results for the third quarter of 2023, disclosing that “[t]he quarter was overshadowed by lower-than-expected U.S. revenue and $63.1 millio...

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Mersana Therapeutics, Inc. (NasdaqGS: MRSN) to Day One Biopharmaceuticals, Inc. Under the terms of the proposed transaction, shareholders of Mersana will receive $25.00 per share in cash plus one non-tradable contingent value right (CVR) per share to receive certain potential milestone payments...